Exact Mass: 276.0859

Exact Mass Matches: 276.0859

Found 155 metabolites which its exact mass value is equals to given mass value 276.0859, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glutamylglutamic acid

(2S)-2-[(2S)-2-amino-4-carboxybutanamido]pentanedioic acid

C10H16N2O7 (276.0957)


Glutamylglutamic acid is a dipeptide composed of two glutamic acid residues, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylglutamic acid is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. KEIO_ID G043; [MS2] KO008970 KEIO_ID G043

   

Ranunculin

(5S)-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]-5H-furan-2-one

C11H16O8 (276.0845)


   

Gamma-glutamylglutamate

(2S)-2-[(4S)-4-amino-4-carboxybutanamido]pentanedioic acid

C10H16N2O7 (276.0957)


gammaGlutamylglutamic acid is made of two glutamic acid molecules. Glutamic acid (Glu), also referred to as glutamate (the anion), is one of the 20 proteinogenic amino acids. It is not among the essential amino acids. Glutamate is a key molecule in cellular metabolism. In humans, dietary proteins are broken down by digestion into amino acids, which serves as metabolic fuel or other functional roles in the body. Glutamate is the most abundant fast excitatory neurotransmitter in the mammalian nervous system. At chemical synapses, glutamate is stored in vesicles. Nerve impulses trigger release of glutamate from the pre-synaptic cell. In the opposing post-synaptic cell, glutamate receptors, such as the NMDA receptor, bind glutamate and are activated. Because of its role in synaptic plasticity, it is believed that glutamic acid is involved in cognitive functions like learning and memory in the brain. Glutamate transporters are found in neuronal and glial membranes. They rapidly remove glutamate from the extracellular space. In brain injury or disease, they can work in reverse and excess glutamate can accumulate outside cells. This process causes calcium ions to enter cells via NMDA receptor channels, leading to neuronal damage and eventual cell death, and is called excitotoxicity. The mechanisms of cell death include: * Damage to mitochondria from excessively high intracellular Ca2+. * Glu/Ca2+-mediated promotion of transcription factors for pro-apoptotic genes, or downregulation of transcription factors for anti-apoptotic genes. Excitotoxicity due to glutamate occurs as part of the ischemic cascade and is associated with stroke and diseases like amyotrophic lateral sclerosis, lathyrism, and Alzheimers disease. glutamic acid has been implicated in epileptic seizures. Microinjection of glutamic acid into neurons produces spontaneous depolarization around one second apart, and this firing pattern is similar to what is known as paroxysmal depolarizing shift in epileptic attacks. This change in the resting membrane potential at seizure foci could cause spontaneous opening of voltage activated calcium channels, leading to glutamic acid release and further depolarization. (http://en.wikipedia.org/wiki/Glutamic_acid) [HMDB] gamma-Glutamylglutamic acid is a dipeptide composed of gamma-glutamate and glutamic acid. Glutamic acid (Glu), also referred to as glutamate (the anion), is one of the 20 proteinogenic amino acids. It is not among the essential amino acids. Glutamate is a key molecule in cellular metabolism. In humans, dietary proteins are broken down by digestion into amino acids, which serve as metabolic fuel and other functional roles in the body. Glutamate is the most abundant fast excitatory neurotransmitter in the mammalian nervous system. At chemical synapses, glutamate is stored in vesicles. Nerve impulses trigger release of glutamate from the pre-synaptic cell. In the opposing post-synaptic cell, glutamate receptors, such as the NMDA receptor, bind glutamate and are activated. Because of its role in synaptic plasticity, it is believed that glutamic acid is involved in cognitive functions like learning and memory in the brain. Glutamate transporters are found in neuronal and glial membranes. They rapidly remove glutamate from the extracellular space. In brain injury or disease, they can work in reverse and excess glutamate can accumulate outside cells. This process causes calcium ions to enter cells via NMDA receptor channels, leading to neuronal damage and eventual cell death, and is called excitotoxicity. The mechanisms of cell death include: (1) damage to mitochondria from excessively high intracellular Ca2+ (2) Glu/Ca2+-mediated promotion of transcription factors for pro-apoptotic genes, or downregulation of transcription factors for anti-apoptotic genes. Excitotoxicity due to glutamate occurs as part of the ischemic cascade and is associated with stroke and diseases like amyotrophic lateral sclerosis, lathyrism, and Alzheimers disease. Glutamic acid has been implicated in epileptic seizures. Microinjection of glutamic acid into neurons produce spontaneous depolarization around one second apart, and this firing pattern is similar to what is known as paroxysmal depolarizing shift in epileptic attacks. This change in the resting membrane potential at seizure foci could cause spontaneous opening of voltage activated calcium channels, leading to glutamic acid release and further depolarization (Wikipedia).

   

Benzo[ghi]perylene

hexacyclo[12.8.0.0^{2,11}.0^{3,8}.0^{4,21}.0^{17,22}]docosa-1(14),2,4,6,8,10,12,15,17(22),18,20-undecaene

C22H12 (276.0939)


   

Indeno[1,2,3-cd]pyrene

hexacyclo[16.3.1.0^{2,7}.0^{8,21}.0^{11,20}.0^{14,19}]docosa-1(22),2,4,6,8(21),9,11(20),12,14(19),15,17-undecaene

C22H12 (276.0939)


   

Anthanthrene

Naphtho[7,8,1,2,3-nopqr]tetraphene

C22H12 (276.0939)


   

Biotin sulfone

5-[(3aS,4S,6aR)-2,5,5-trioxo-hexahydro-1H-5λ⁶-thieno[3,4-d]imidazolidin-4-yl]pentanoic acid

C10H16N2O5S (276.078)


Biotin sulfone is a natural biotin metabolite in human urine. (PMID 9039841). The urinary excretion of biotin sulfone a increased with biotin administration. (PMID 9022537). Biotin sulfone is first isolated as a natural metabolite of biotin.

   

Tabtoxin biosynthesis intermediate 2

C20912; Tabtoxin biosynthesis intermediate 2

C10H16N2O7 (276.0957)


   

Clenbuterol

4-Amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol

C12H18Cl2N2O (276.0796)


Clenbuterol is only found in individuals that have used or taken this drug. It is a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. [PubChem]Clenbuterol is a Beta(2) agonist similar in some structural respects to salbutamol. Agonism of the beta(2) receptor stimulates adenylyl cyclase activity which ultimately leads to downstream effects of smooth muscle relaxation in the bronchioles. Potential food contaminant arising from its illicit use to improve carcass quality and productivity in cattle. Approved tocolytic agent for cows in several European countries R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

   

Thymidine glycol

4,5,6-trihydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,5,6-tetrahydropyrimidin-2-one

C10H16N2O7 (276.0957)


Thymidine glycol belongs to the family of Pyrimidine 2-deoxyribonucleosides and Analogues. These are compounds consisting of a pyrimidine linked to a ribose which lacks an hydroxyl group at position 2.

   

2-[(E)-2-(3-Nitrophenyl)vinyl]quinoline

2-[(E)-2-(3-Nitrophenyl)vinyl]quinoline

C17H12N2O2 (276.0899)


   

3',4'-Dihydroxyflurbiprofen

2-{2-fluoro-3,4-dihydroxy-[1,1-biphenyl]-4-yl}propanoic acid

C15H13FO4 (276.0798)


   

D-gamma-Glutamyl-D-glutamic acid

2-(4-amino-4-carboxybutanamido)pentanedioic acid

C10H16N2O7 (276.0957)


   

Meisoindigo

2-hydroxy-1-methyl-1H,2H-[3,3-biindole]-2-one

C17H12N2O2 (276.0899)


Meisoindigo (Dian III), a derivative of Indirubin (HY-N0117), halts the cell cycle at the G0/G1 phase and induces apoptosis in primary acute myeloid leukemia (AML) cells. Meisoindigo exhibits high antitumor activity[1][2].

   

1-Phenyl-1,4-epoxy-1h,4h-naphtho[1,8-de][1,2]dioxepin

10-phenyl-11,12,15-trioxatetracyclo[7.4.1.1^{10,13}.0^{5,14}]pentadeca-1,3,5(14),6,8-pentaene

C18H12O3 (276.0786)


   

Tanshinone I

6,14-dimethyl-12-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),2(7),3,5,8,11(15),13-heptaene-16,17-dione

C18H12O3 (276.0786)


   

TTE-50

InChI=1/C18H12O3/c1-9-4-3-5-12-11(9)6-7-13-15(12)17(20)16(19)14-10(2)8-21-18(13)14/h3-8H,1-2H3

C18H12O3 (276.0786)


Tanshinone I is an abietane diterpenoid. It has a role as an anticoronaviral agent. Tanshinone I is a natural product found in Salvia miltiorrhiza, Salvia digitaloides, and other organisms with data available. See also: Salvia Miltiorrhiza Root (part of). D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants D000893 - Anti-Inflammatory Agents D000890 - Anti-Infective Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM).

   

6,8-Dihydroxy-4-methyl-7H-benz[de]anthracen-7-one

6,8-Dihydroxy-4-methyl-7H-benz[de]anthracen-7-one

C18H12O3 (276.0786)


   
   

Isotanshinone II

Isotanshinone II

C18H12O3 (276.0786)


   

3-Hydroxy-4-phenyl-1H,3H-naphtho[1,8-cd]pyran-1-one

3-Hydroxy-4-phenyl-1H,3H-naphtho[1,8-cd]pyran-1-one

C18H12O3 (276.0786)


   

Maybridge1_003784

Maybridge1_003784

C14H16N2O2S (276.0932)


   
   

Ethyl 2-cyano-3-[2-(2-thienyl)tetrahydro-1H-pyrrol-1-yl]acrylate

Ethyl 2-cyano-3-[2-(2-thienyl)tetrahydro-1H-pyrrol-1-yl]acrylate

C14H16N2O2S (276.0932)


   

2-Phenyl-2-[4-(trifluoromethyl)anilino]acetonitrile

2-Phenyl-2-[4-(trifluoromethyl)anilino]acetonitrile

C15H11F3N2 (276.0874)


   
   

tanshinone I

tanshinone I

C18H12O3 (276.0786)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants D000893 - Anti-Inflammatory Agents D000890 - Anti-Infective Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM).

   

Tryptophan. N-(1-thioxorthyl)-methyl ester

Tryptophan. N-(1-thioxorthyl)-methyl ester

C14H16N2O2S (276.0932)


   
   

gamma-glutamyl-S-ethenylcysteine

gamma-glutamyl-S-ethenylcysteine

C10H16N2O5S (276.078)


   

Ranuncoside

Ranuncoside

C11H16O8 (276.0845)


   
   
   

SCHEMBL17867067

SCHEMBL17867067

C18H12O3 (276.0786)


   

CHEMBL477331

CHEMBL477331

C18H12O3 (276.0786)


   

2,3-diacetamido-2,3-dideoxy-L-guluronic acid

2,3-diacetamido-2,3-dideoxy-L-guluronic acid

C10H16N2O7 (276.0957)


   

Cryptolepinoic acid

Cryptolepinoic acid

C17H12N2O2 (276.0899)


   
   
   

3-Chloro-2-oxo-1(10), 3, 7(11), 8-guiatetraen-12, 6-olide

3-Chloro-2-oxo-1(10), 3, 7(11), 8-guiatetraen-12, 6-olide

C16H17ClO2 (276.0917)


   

6,8-dihydroxy-4-methyl-7 h-benz(de) anthracen-7-one

6,8-dihydroxy-4-methyl-7 h-benz(de) anthracen-7-one

C18H12O3 (276.0786)


   
   

Isotanshinone I

Isotanshinone I

C18H12O3 (276.0786)


   

Siphonoside

Siphonoside

C11H16O8 (276.0845)


   

pestalochromone B

pestalochromone B

C12H17ClO5 (276.0764)


   

(S,S)-gamma-glutamyl-(cis-S-1-propenyl)thioglycine|gamma-glutamyl-cis-S-1-propenyl-L-cysteine

(S,S)-gamma-glutamyl-(cis-S-1-propenyl)thioglycine|gamma-glutamyl-cis-S-1-propenyl-L-cysteine

C10H16N2O5S (276.078)


   

8-methoxy-1,2-methylenedioxypyrene

8-methoxy-1,2-methylenedioxypyrene

C18H12O3 (276.0786)


   

Protoanemonin hydrate glucoside

Protoanemonin hydrate glucoside

C11H16O8 (276.0845)


   

Xylopyranose triacetate

Xylopyranose triacetate

C11H16O8 (276.0845)


   

1H-Dibenzo(de,g)quinolin-1-one, 7-amino-2-methoxy-

1H-Dibenzo(de,g)quinolin-1-one, 7-amino-2-methoxy-

C17H12N2O2 (276.0899)


   

Indeno[1,2,3-cd]fluoranthene

Indeno[1,2,3-cd]fluoranthene

C22H12 (276.0939)


   

Isoranunculin

Isoranunculin

C11H16O8 (276.0845)


   

dian III

1-Methyl-[3,3 inverted exclamation mark -biindolinylidene]-2,2 inverted exclamation mark -dione

C17H12N2O2 (276.0899)


Meisoindigo (Dian III), a derivative of Indirubin (HY-N0117), halts the cell cycle at the G0/G1 phase and induces apoptosis in primary acute myeloid leukemia (AML) cells. Meisoindigo exhibits high antitumor activity[1][2].

   

clenbuterol

(+)-4-amino-alpha-[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol

C12H18Cl2N2O (276.0796)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists CONFIDENCE standard compound; EAWAG_UCHEM_ID 3592 CONFIDENCE standard compound; INTERNAL_ID 1099

   

5,6-Dihydroxydihydro-thymidine

5,6-Dihydroxydihydro-thymidine

C10H16N2O7 (276.0957)


   
   

3,4-Dihydroxyflurbiprofen

3,4-Dihydroxyflurbiprofen

C15H13FO4 (276.0798)


   

Biotin sulfone

Biotin sulfone

C10H16N2O5S (276.078)


A member of the class of biotins that is biotin sulfoxide with a sulfone group replacing the sulfoxide. Biotin sulfone is first isolated as a natural metabolite of biotin.

   

Thymidine glycol

4,5,6-trihydroxy-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,5,6-tetrahydropyrimidin-2-one

C10H16N2O7 (276.0957)


   

Chlorobis(3,5-dimethylphenyl)phosphine

Chlorobis(3,5-dimethylphenyl)phosphine

C16H18ClP (276.0835)


   

2,3-Didehydro-2,3-dideoxy-5-acetate inosine

2,3-Didehydro-2,3-dideoxy-5-acetate inosine

C12H12N4O4 (276.0859)


   

3-benzoylnaphthalene-2-carboxylic acid

3-benzoylnaphthalene-2-carboxylic acid

C18H12O3 (276.0786)


   

3-amino-4,4-dimethylbenzenesulfonanilide

3-amino-4,4-dimethylbenzenesulfonanilide

C14H16N2O2S (276.0932)


   

(r)-(-)-2,2,2-trifluoro-1-(9-anthryl)ethanol

(r)-(-)-2,2,2-trifluoro-1-(9-anthryl)ethanol

C16H11F3O (276.0762)


   

2,5-Bis[(trimethylsilyl)ethynyl]thiophene

2,5-Bis[(trimethylsilyl)ethynyl]thiophene

C14H20SSi2 (276.0824)


   

1-(NAPHTHALENE-2-SULFONYL)-PIPERAZINE

1-(NAPHTHALENE-2-SULFONYL)-PIPERAZINE

C14H16N2O2S (276.0932)


   

N-(4-methoxyphenyl)benzene-1,4-diamine; sulfuric acid

N-(4-methoxyphenyl)benzene-1,4-diamine; sulfuric acid

C13H13ClN4O (276.0778)


   

1-(BENZYLOXY)-4-(3-CHLOROPROPOXY)BENZENE

1-(BENZYLOXY)-4-(3-CHLOROPROPOXY)BENZENE

C16H17ClO2 (276.0917)


   

Benzenesulfonanilide, 2-amino-N-ethyl-

Benzenesulfonanilide, 2-amino-N-ethyl-

C14H16N2O2S (276.0932)


   

2-(2-ETHYL-PYRIDIN-4-YL)-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

2-(2-ETHYL-PYRIDIN-4-YL)-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID ETHYL ESTER

C14H16N2O2S (276.0932)


   

ethyl 5-amino-1-(3-nitrophenyl)pyrazole-4-carboxylate

ethyl 5-amino-1-(3-nitrophenyl)pyrazole-4-carboxylate

C12H12N4O4 (276.0859)


   

5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL AZIRIDINE

5-DIMETHYLAMINONAPHTHALENE-1-SULFONYL AZIRIDINE

C14H16N2O2S (276.0932)


   

4-Amino-N-ethyl-N-phenylbenzenesulfonamide

4-Amino-N-ethyl-N-phenylbenzenesulfonamide

C14H16N2O2S (276.0932)


   

4-Amino-N-(3,4-dimethylphenyl)benzenesulfonamide

4-Amino-N-(3,4-dimethylphenyl)benzenesulfonamide

C14H16N2O2S (276.0932)


   
   

ETHYL5-AMINO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL5-AMINO-1-(2-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C12H12N4O4 (276.0859)


   

Ethyl 2-[4-(dimethylamino)phenyl]-1,3-thiazole-4-carboxylate

Ethyl 2-[4-(dimethylamino)phenyl]-1,3-thiazole-4-carboxylate

C14H16N2O2S (276.0932)


   

(+)-Pirkles Alcohol

(+)-Pirkles Alcohol

C16H11F3O (276.0762)


   

ETHYL5-AMINO-1-(4-NITROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

ETHYL5-AMINO-1-(4-NITROPHENYL)-1H-PYRAZOLE-3-CARBOXYLATE

C12H12N4O4 (276.0859)


   

5-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)BENZOFURAN

5-METHYL-2-(3-(TRIFLUOROMETHYL)PHENYL)BENZOFURAN

C16H11F3O (276.0762)


   

Tetramethyl 1,1,2,3-Propanetetracarboxylate

Tetramethyl 1,1,2,3-Propanetetracarboxylate

C11H16O8 (276.0845)


   
   

4-amino-N-(2,6-dimethylphenyl)benzenesulfonamide

4-amino-N-(2,6-dimethylphenyl)benzenesulfonamide

C14H16N2O2S (276.0932)


   

[6-Phenyl-2,2-bipyridine]-4-carboxylic acid

[6-Phenyl-2,2-bipyridine]-4-carboxylic acid

C17H12N2O2 (276.0899)


   

Di-o-tolyl Methylphosphonate

Di-o-tolyl Methylphosphonate

C15H17O3P (276.0915)


   

2-(1-Naphthoyl)benzoic acid

2-(1-Naphthoyl)benzoic acid

C18H12O3 (276.0786)


   

Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-

Propanedinitrile, 2-[Methoxy(4-phenoxyphenyl)Methylene]-

C17H12N2O2 (276.0899)


   

Benzenesulfonic acid,4-methyl-, 2-phenylethyl ester

Benzenesulfonic acid,4-methyl-, 2-phenylethyl ester

C15H16O3S (276.082)


   

N-[3-[(Dimethylamino)methylene]-3,4-dihydro-4-oxo-2H-1-benzothiopyran-6-yl]acetamide

N-[3-[(Dimethylamino)methylene]-3,4-dihydro-4-oxo-2H-1-benzothiopyran-6-yl]acetamide

C14H16N2O2S (276.0932)


   

4(3H)-Quinazolinone,7-(4-morpholinyl)-6-nitro-

4(3H)-Quinazolinone,7-(4-morpholinyl)-6-nitro-

C12H12N4O4 (276.0859)


   

ethyl 6-methyl-4-phenyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate

ethyl 6-methyl-4-phenyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate

C14H16N2O2S (276.0932)


   

cathepsin d

cathepsin d

C15H16O3S (276.082)


   

3-(Aminomethyl)-4-chloro-N-isobutylbenzamide hydrochloride

3-(Aminomethyl)-4-chloro-N-isobutylbenzamide hydrochloride

C12H18Cl2N2O (276.0796)


   

2,4-Difluorophenyl-(4-piperidinyl) methanone oxime hydrochloride

2,4-Difluorophenyl-(4-piperidinyl) methanone oxime hydrochloride

C12H15ClF2N2O (276.0841)


   

ETHYL5-AMINO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

ETHYL5-AMINO-1-(4-NITROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C12H12N4O4 (276.0859)


   

2,2,2-Trifluoro-1-(9-anthryl)ethanol

2,2,2-Trifluoro-1-(9-anthryl)ethanol

C16H11F3O (276.0762)


   

Ketoprofen sodium

Ketoprofen sodium

C16H13NaO3 (276.0762)


   

Oxifungin hydrochloride

Oxifungin hydrochloride

C13H13ClN4O (276.0778)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

2-[(E)-2-(3-Nitrophenyl)vinyl]quinoline

2-[(E)-2-(3-Nitrophenyl)vinyl]quinoline

C17H12N2O2 (276.0899)


   

(5-hydroxy-1H-indol-2-yl)-(1H-indol-2-yl)methanone

(5-hydroxy-1H-indol-2-yl)-(1H-indol-2-yl)methanone

C17H12N2O2 (276.0899)


   

3-(8-Methyl-2-imidazo[1,2-a]pyridinyl)-1-benzopyran-2-one

3-(8-Methyl-2-imidazo[1,2-a]pyridinyl)-1-benzopyran-2-one

C17H12N2O2 (276.0899)


   
   

3-Phenyl-1,4-dihydropyrrolo[1,2-a]quinazoline-2,5-dione

3-Phenyl-1,4-dihydropyrrolo[1,2-a]quinazoline-2,5-dione

C17H12N2O2 (276.0899)


   

H-Glu(D-Glu-OH)-OH

H-Glu(D-Glu-OH)-OH

C10H16N2O7 (276.0957)


   

N-(5-tert-butyl-1,3-thiazol-2-yl)-2-hydroxybenzamide

N-(5-tert-butyl-1,3-thiazol-2-yl)-2-hydroxybenzamide

C14H16N2O2S (276.0932)


   

Thiamylal sodium

Thiamylal sodium

C12H17N2NaO2S (276.0908)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C67084 - Barbiturate D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Tanshinon I

1,6-dimethylnaphtho[1,2-g][1]benzoxole-10,11-dione

C18H12O3 (276.0786)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D000925 - Anticoagulants D000893 - Anti-Inflammatory Agents D000890 - Anti-Infective Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM). Tanshinone I is an inhibitor of type IIA human recombinant sPLA2 (IC50=11 μM) and rabbit recombinant cPLA2 (IC50=82 μM).

   

D-gamma-Glutamyl-D-glutamic acid

D-gamma-Glutamyl-D-glutamic acid

C10H16N2O7 (276.0957)


   

1-(2-Chlorophenyl)-4-phenylbutane-1,2-diol

1-(2-Chlorophenyl)-4-phenylbutane-1,2-diol

C16H17ClO2 (276.0917)


   

2,3-Bis(acetylamino)-2,3-dideoxy-alpha-D-mannopyranuronic acid

2,3-Bis(acetylamino)-2,3-dideoxy-alpha-D-mannopyranuronic acid

C10H16N2O7 (276.0957)


   

N-Cyclohexyl-5-(thiophen-2-yl)isoxazole-3-carboxamide

N-Cyclohexyl-5-(thiophen-2-yl)isoxazole-3-carboxamide

C14H16N2O2S (276.0932)


   

2,3,4-trimethyl-N-(3-pyridinyl)benzenesulfonamide

2,3,4-trimethyl-N-(3-pyridinyl)benzenesulfonamide

C14H16N2O2S (276.0932)


   

6-methyl-5-[2-(2-methylphenoxy)ethyl]-2-sulfanylidene-1H-pyrimidin-4-one

6-methyl-5-[2-(2-methylphenoxy)ethyl]-2-sulfanylidene-1H-pyrimidin-4-one

C14H16N2O2S (276.0932)


   

(S)-(+)-clenbuterol

(+)-4-amino-alpha-[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol

C12H18Cl2N2O (276.0796)


   

N-(5-ethyl-4-phenyl-1,3-thiazol-2-yl)-2-methoxyacetamide

N-(5-ethyl-4-phenyl-1,3-thiazol-2-yl)-2-methoxyacetamide

C14H16N2O2S (276.0932)


   

1-[(2-Ethoxyphenyl)methyl]-3-thiophen-2-ylurea

1-[(2-Ethoxyphenyl)methyl]-3-thiophen-2-ylurea

C14H16N2O2S (276.0932)


   

3,4,5-Trihydroxy-6-(3-methylbut-2-enoyloxy)oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-(3-methylbut-2-enoyloxy)oxane-2-carboxylic acid

C11H16O8 (276.0845)


   

3,4,5-trihydroxy-6-[(E)-2-methylbut-2-enoyl]oxyoxane-2-carboxylic acid

3,4,5-trihydroxy-6-[(E)-2-methylbut-2-enoyl]oxyoxane-2-carboxylic acid

C11H16O8 (276.0845)


   

4-Benzoyl-6-phenyl-2H-pyran-2-one

4-Benzoyl-6-phenyl-2H-pyran-2-one

C18H12O3 (276.0786)


   

Indeno[1,2,3-cd]pyrene

Indeno[1,2,3-cd]pyrene

C22H12 (276.0939)


   

gamma-Glutamylglutamate

gamma-Glutamylglutamate

C10H16N2O7 (276.0957)


   

Glu-Glu

Glu-Glu

C10H16N2O7 (276.0957)


A dipeptide composed of two L-glutamic acid units joined by a peptide linkage.

   

Benzo[ghi]perylene

Benzo[ghi]perylene

C22H12 (276.0939)


   

2-[4-(3,4-Dihydroxyphenyl)-3-fluorophenyl]propanoic acid

2-[4-(3,4-Dihydroxyphenyl)-3-fluorophenyl]propanoic acid

C15H13FO4 (276.0798)


   

gamma-Glu-Glu

gamma-Glu-Glu

C10H16N2O7 (276.0957)


A dipeptide obtained by formal condensation of the gamma-carboxy group of glutamic acid with the amino group of another glutamic acid.

   

3,8-dimethylphenanthro[4,3-b]furan-4,5-dione

3,8-dimethylphenanthro[4,3-b]furan-4,5-dione

C18H12O3 (276.0786)


   

(5s,6r,7r,8r)-8-chloro-6,7-dihydroxy-5-methoxy-2,2-dimethyl-5,6,7,8-tetrahydro-3h-1-benzopyran-4-one

(5s,6r,7r,8r)-8-chloro-6,7-dihydroxy-5-methoxy-2,2-dimethyl-5,6,7,8-tetrahydro-3h-1-benzopyran-4-one

C12H17ClO5 (276.0764)


   

(2s,4'as,6'r,7'r,8's,8'ar)-7',8'-dihydroxy-6'-(hydroxymethyl)-hexahydrospiro[oxolane-2,2'-pyrano[2,3-b][1,4]dioxin]-5-one

(2s,4'as,6'r,7'r,8's,8'ar)-7',8'-dihydroxy-6'-(hydroxymethyl)-hexahydrospiro[oxolane-2,2'-pyrano[2,3-b][1,4]dioxin]-5-one

C11H16O8 (276.0845)


   

(2s)-2-amino-4-{[(1s)-1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1s)-1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H16N2O5S (276.078)


   

(2r,3r,4s,5s,6r)-2-[(5-hydroxyfuran-2-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-[(5-hydroxyfuran-2-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C11H16O8 (276.0845)


   

(2s)-2-{[(2s)-2-amino-4-carboxy-1-hydroxybutylidene]amino}pentanedioic acid

(2s)-2-{[(2s)-2-amino-4-carboxy-1-hydroxybutylidene]amino}pentanedioic acid

C10H16N2O7 (276.0957)


   

5-methylindolo[3,2-b]quinoline-11-carboxylic acid

5-methylindolo[3,2-b]quinoline-11-carboxylic acid

C17H12N2O2 (276.0899)


   

(5s,6r,7r,8s)-8-chloro-6,7-dihydroxy-5-methoxy-2,2-dimethyl-5,6,7,8-tetrahydro-3h-1-benzopyran-4-one

(5s,6r,7r,8s)-8-chloro-6,7-dihydroxy-5-methoxy-2,2-dimethyl-5,6,7,8-tetrahydro-3h-1-benzopyran-4-one

C12H17ClO5 (276.0764)


   

3,6-dihydroxy-4,5-bis[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

3,6-dihydroxy-4,5-bis[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

C10H16N2O7 (276.0957)


   

4,8-dimethylphenanthro[3,2-b]furan-7,11-dione

4,8-dimethylphenanthro[3,2-b]furan-7,11-dione

C18H12O3 (276.0786)


   

5-methyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-furan-3-one

5-methyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-furan-3-one

C11H16O8 (276.0845)


   

(4r,5r,6s)-5-chloro-4,6-dihydroxy-3-[3-(2-hydroxypropan-2-yl)oxiran-2-yl]-6-methylcyclohex-2-en-1-one

(4r,5r,6s)-5-chloro-4,6-dihydroxy-3-[3-(2-hydroxypropan-2-yl)oxiran-2-yl]-6-methylcyclohex-2-en-1-one

C12H17ClO5 (276.0764)


   

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}pentanedioic acid

(2s)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}pentanedioic acid

C10H16N2O7 (276.0957)


   

3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5h-furan-2-one

3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5h-furan-2-one

C11H16O8 (276.0845)


   

5-chloro-4,6-dihydroxy-3-[3-(2-hydroxypropan-2-yl)oxiran-2-yl]-6-methylcyclohex-2-en-1-one

5-chloro-4,6-dihydroxy-3-[3-(2-hydroxypropan-2-yl)oxiran-2-yl]-6-methylcyclohex-2-en-1-one

C12H17ClO5 (276.0764)


   

7',8'-dihydroxy-6'-(hydroxymethyl)-hexahydrospiro[oxolane-2,2'-pyrano[2,3-b][1,4]dioxin]-5-one

7',8'-dihydroxy-6'-(hydroxymethyl)-hexahydrospiro[oxolane-2,2'-pyrano[2,3-b][1,4]dioxin]-5-one

C11H16O8 (276.0845)


   

2-amino-4-{[1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H16N2O5S (276.078)


   

6,10-dihydroxy-11-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

6,10-dihydroxy-11-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

C18H12O3 (276.0786)


   

3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5h-furan-2-one

3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-5h-furan-2-one

C11H16O8 (276.0845)


   

10-amino-11-methoxy-16-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

10-amino-11-methoxy-16-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

C17H12N2O2 (276.0899)


   

6,10-dihydroxy-12-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

6,10-dihydroxy-12-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one

C18H12O3 (276.0786)


   

(2e)-3-[(2r)-butan-2-yldisulfanyl]prop-2-en-1-yl (2e)-2-(hydroxymethyl)but-2-enoate

(2e)-3-[(2r)-butan-2-yldisulfanyl]prop-2-en-1-yl (2e)-2-(hydroxymethyl)but-2-enoate

C12H20O3S2 (276.0854)


   

3-[(2r)-butan-2-yldisulfanyl]prop-2-en-1-yl 2-(hydroxymethyl)but-2-enoate

3-[(2r)-butan-2-yldisulfanyl]prop-2-en-1-yl 2-(hydroxymethyl)but-2-enoate

C12H20O3S2 (276.0854)


   

16-amino-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one

16-amino-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one

C17H12N2O2 (276.0899)


   

6,10-dihydroxy-4-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one

6,10-dihydroxy-4-methyltetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-8-one

C18H12O3 (276.0786)


   

8-chloro-6,7-dihydroxy-5-methoxy-2,2-dimethyl-5,6,7,8-tetrahydro-3h-1-benzopyran-4-one

8-chloro-6,7-dihydroxy-5-methoxy-2,2-dimethyl-5,6,7,8-tetrahydro-3h-1-benzopyran-4-one

C12H17ClO5 (276.0764)


   

5-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-furan-3-one

5-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2h-furan-3-one

C11H16O8 (276.0845)


   

(2r,3s,4r,5s,6r)-3,6-dihydroxy-4,5-bis[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

(2r,3s,4r,5s,6r)-3,6-dihydroxy-4,5-bis[(1-hydroxyethylidene)amino]oxane-2-carboxylic acid

C10H16N2O7 (276.0957)


   

(2s)-2-amino-4-{[(1r)-1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-carboxy-2-(ethenylsulfanyl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H16N2O5S (276.078)